Solid Organ Transplantation After Hematopoietic Cell Transplantation: Is the Evidence Solid Enough?
作者信息
Puttarajappa Chethan M
机构信息
Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh, Pittsburgh, PA.
出版信息
Transplantation. 2025 Jun 23. doi: 10.1097/TP.0000000000005366.
Abstract
摘要
相似文献
1
Solid Organ Transplantation After Hematopoietic Cell Transplantation: Is the Evidence Solid Enough?造血细胞移植后的实体器官移植：证据是否足够确凿？
Transplantation. 2025 Jun 23. doi: 10.1097/TP.0000000000005366.
2
Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.血小板生成素受体激动剂用于预防和治疗实体瘤患者化疗引起的血小板减少症。
Cochrane Database Syst Rev. 2017 Nov 27;11(11):CD012035. doi: 10.1002/14651858.CD012035.pub2.
3
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
4
Risk Factors for Solid Organ Graft Failure and Death in Hematopoietic Cell Transplant Recipients Undergoing Solid Organ Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research and Organ Procurement and Transplantation Network Study.接受实体器官移植的造血细胞移植受者实体器官移植失败和死亡的风险因素：一项国际血液和骨髓移植研究中心及器官获取与移植网络的回顾性研究。
Transplantation. 2025 Jun 23. doi: 10.1097/TP.0000000000005397.
5
Hematopoietic cell-based and non-hematopoietic cell-based strategies for immune tolerance induction in living-donor renal transplantation: A systematic review.基于造血细胞和非造血细胞的活体供肾移植免疫耐受诱导策略：一项系统综述。
Transplant Rev (Orlando). 2023 Dec;37(4):100792. doi: 10.1016/j.trre.2023.100792. Epub 2023 Aug 19.
6
WITHDRAWN: Cytomegalovirus prophylaxis with antiviral agents for solid organ transplantation.撤回：实体器官移植中使用抗病毒药物进行巨细胞病毒预防。
Cochrane Database Syst Rev. 2007 Jul 18;1998(4):CD001320. doi: 10.1002/14651858.CD001320.pub2.
7
Risk Factors for Solid Organ Graft Failure and Death in Solid Organ Transplant Recipients Undergoing Hematopoietic Cell Transplantation: A Retrospective Center for International Blood and Marrow Transplant Research (CIBMTR) and Organ Procurement and Transplantation Network (OPTN) Study.接受造血细胞移植的实体器官移植受者发生实体器官移植失败和死亡的危险因素：一项国际血液和骨髓移植研究中心（CIBMTR）与器官获取与移植网络（OPTN）的回顾性研究。
Transplantation. 2025 Jun 23. doi: 10.1097/TP.0000000000005377.
8
Subclinical cardiovascular changes in pediatric solid organ transplant recipients: A systematic review and meta-analysis.小儿实体器官移植受者的亚临床心血管变化：一项系统评价和荟萃分析。
Pediatr Transplant. 2016 Jun;20(4):530-9. doi: 10.1111/petr.12689. Epub 2016 Feb 18.
9
Allogeneic Hematopoietic Stem Cell Transplantation After Solid Organ Transplantation in Patients With Hematologic Malignancies Managed With Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis.采用基于移植后环磷酰胺的移植物抗宿主病预防方案治疗血液系统恶性肿瘤的实体器官移植患者的异基因造血干细胞移植
J Hematol. 2024 Oct;13(5):250-258. doi: 10.14740/jh1327. Epub 2024 Oct 21.
10
Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.提高实体器官移植受者免疫抑制剂药物依从性的干预措施。
Cochrane Database Syst Rev. 2022 Sep 12;9(9):CD012854. doi: 10.1002/14651858.CD012854.pub2.
本文引用的文献
1
Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice.实体器官移植受者巨细胞病毒感染：美国移植感染病学会实践社区指南。
Clin Transplant. 2019 Sep;33(9):e13512. doi: 10.1111/ctr.13512. Epub 2019 Mar 28.
2
Long-term complications after hematopoietic cell transplantation.造血细胞移植后的长期并发症。
Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):220-227. doi: 10.1016/j.hemonc.2017.05.009. Epub 2017 Jun 13.
3
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.美国国立卫生研究院造血细胞移植迟发效应倡议：以患者为中心的结局工作组报告。
Biol Blood Marrow Transplant. 2017 Apr;23(4):538-551. doi: 10.1016/j.bbmt.2016.09.011. Epub 2016 Sep 19.
4
Surviving the cure: long term followup of hematopoietic cell transplant recipients.治愈后的生存：造血细胞移植受者的长期随访。
Bone Marrow Transplant. 2013 Sep;48(9):1145-51. doi: 10.1038/bmt.2012.258. Epub 2013 Jan 7.
5
Solid organ transplantation after allogeneic hematopoietic stem cell transplantation: a retrospective, multicenter study of the EBMT.异基因造血干细胞移植后实体器官移植：EBMT 的回顾性多中心研究。
Am J Transplant. 2010 Aug;10(8):1897-906. doi: 10.1111/j.1600-6143.2010.03187.x.
6
Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.异基因造血细胞移植后长期生存者的慢性肾脏病：患病率和危险因素。
Nephrol Dial Transplant. 2010 Jan;25(1):278-82. doi: 10.1093/ndt/gfp485. Epub 2009 Sep 17.
Zotero 插件